SOHO Global Health, headquartered in Indonesia, is a prominent player in the pharmaceutical and healthcare industry, specialising in the development and distribution of high-quality medicines and healthcare products. Founded in 2012, the company has rapidly expanded its operations across Southeast Asia, establishing a strong presence in key markets. With a focus on innovative healthcare solutions, SOHO Global Health offers a diverse range of products, including prescription medications, over-the-counter drugs, and nutritional supplements. Their commitment to quality and sustainability sets them apart in a competitive landscape. Recognised for their excellence, the company has achieved significant milestones, including various certifications and partnerships that enhance their market position. As a trusted name in healthcare, SOHO Global Health continues to contribute to the well-being of communities throughout the region.
How does SOHO Global Health's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
SOHO Global Health's score of 13 is lower than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, SOHO Global Health reported total carbon emissions of approximately 7,762,890 kg CO2e. This figure includes emissions from Scope 1, Scope 2, and Scope 3 sources, with specific contributions of 5,000 kg CO2e from diesel fuel and 2,548,280 kg CO2e from electricity. The company also noted emissions of approximately 3,618,020 kg CO2e from transportation activities. In 2022, the total emissions were approximately 7,810,840 kg CO2e, with Scope 1 emissions at 3,580 kg CO2e and Scope 2 emissions at 7,060,770 kg CO2e. The Scope 3 emissions for that year were approximately 698,540 kg CO2e, primarily from upstream transportation and distribution. SOHO Global Health has not set specific reduction targets or initiatives as part of their climate commitments, and there are no cascading emissions data from a parent company. The organisation is focused on understanding and managing its carbon footprint, but further details on specific climate pledges or initiatives are not available.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | |
|---|---|---|---|
| Scope 1 | 821,950 | 000,000 | 000,000 |
| Scope 2 | 8,469,260 | 0,000,000 | 0,000,000 |
| Scope 3 | 228,930 | 000,000 | 000,000 |
SOHO Global Health's Scope 3 emissions, which increased by 7% last year and increased by approximately 14% since 2019, demonstrating supply chain emissions tracking. Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 3% of total emissions under the GHG Protocol, with "Fuel and Energy Related Activities" being the largest emissions source at 98% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
SOHO Global Health has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

